Early biomarkers of doxorubicin-induced heart injury in a mouse model. - Wikidata - wikimedia - TriplyDB

Early biomarkers of doxorubicin-induced heart injury in a mouse model.

Early biomarkers of doxorubicin-induced heart injury in a mouse model.

http://www.wikidata.org/entity/Q42703425

about

microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment Paving the Route to Plasma miR-208a-3p as an Acute Cardiac Injury Biomarker: Preclinical Rat Data Supports Its Use in Drug Safety Assessment.Anthracycline induced cardiotoxicity: biomarkers and "Omics" technology in the era of patient specific care.Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears Comment on "MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction"Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth.Potential Effects of Pomegranate on Lipid Peroxidation and Pro-inflammatory Changes in Daunorubicin-induced Cardiotoxicity in Rats MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat.Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients.The role for microRNAs in drug toxicity and in safety assessment.Alternative Biomarkers for Combined Biology.MicroRNAs in injury and repair.MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.Sarco"MiR" friend or foe: a perspective on the mechanisms of doxorubicin-induced cardiomyopathy.Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats.Technological Advances in Cardiovascular Safety Assessment Decrease Preclinical Animal Use and Improve Clinical Relevance.Effects of Cyclophosphamide (CYP) and/or Doxorubicin (DOX) in a Murine Model of Post-Chemotherapy Cognitive Impairment.Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients.Downregulation of myogenic microRNAs in sub-chronic but not in sub-acute model of daunorubicin-induced cardiomyopathy.Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients.Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy.Protecting the heart in cancer therapy

P2860

Q26778918-2E204398-182F-42B9-BFD5-8691BE7F1AA4 Q31004210-A67290F6-3E0A-4F59-BFD3-0D632B0C5A1F Q33658456-B5C06447-13DE-4368-A5EE-9130E72E755A Q33816471-0AA5A057-AFD4-4476-9B3A-0FDF922125BB Q35774310-4E02FD75-DD21-45F1-A48C-B8093E917837 Q36409311-ED721A2A-2C29-4D3D-B874-56123DD31DA3 Q36497652-1B959E13-5B5A-4E3A-8282-E9D595880A2A Q37050999-1E0CFFC5-E2CF-45E5-8909-723F4748139A Q37641769-CF8AAF0C-8EB5-4984-AE84-60B368E7739E Q37701713-3FF87151-2A21-4D35-988E-F489C681F521 Q38367620-6664EB98-E032-49E3-811B-0C1CE7457827 Q38747992-96AA6AE7-FD55-4A35-BCE1-66CF052C4461 Q39304689-476822D2-473D-4B6D-AB30-0D89D6D61011 Q40026732-98D4CEC7-C9EB-4FCB-8B5B-2F967CAE9C61 Q41983421-7204E10F-3301-493C-84BD-41A54D4EBE5F Q43151456-6148D937-F64D-4931-962E-8E23E7A43280 Q45967235-6B949876-07C2-44DA-BD05-E7596873FF75 Q47566624-4CD326B5-FD23-400A-B9BF-8EE5E57FFE4F Q47929107-255581E9-AA62-47F9-8E97-4D2A6F47D317 Q47943382-98DF3085-877C-463F-93C9-FEC273BA0943 Q49163835-5F45F7D4-947C-4D2E-A20B-3E5DFFD36D60 Q49353792-28C04EB0-6ADE-4C08-8EA6-8EDB3A2D00B4 Q57821006-AB907E2E-086A-46C7-BB60-C29993CB11B4

P2860

Early biomarkers of doxorubicin-induced heart injury in a mouse model.

http://www.wikidata.org/entity/Q42703425

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Early biomarkers of doxorubicin-induced heart injury in a mouse model.

@en

Early biomarkers of doxorubicin-induced heart injury in a mouse model.

@nl

type

label

Early biomarkers of doxorubicin-induced heart injury in a mouse model.

@en

Early biomarkers of doxorubicin-induced heart injury in a mouse model.

@nl

prefLabel

Early biomarkers of doxorubicin-induced heart injury in a mouse model.

@en

Early biomarkers of doxorubicin-induced heart injury in a mouse model.

@nl

P1433

Q42703425-B57E7CC9-0B93-463F-AE28-79C5E771C0BD

P1476

Q42703425-2B67C15A-612C-4D5C-8431-54E53A22DA9E

P2093

Q42703425-0909DEE2-4A1A-4788-8678-9298A13EACDF

Q42703425-19C39293-464B-46B0-ACD6-8BDDFF8AA07A

Q42703425-21248521-ADCF-46ED-8231-2547C7F743CB

Q42703425-390BB515-D7DA-4196-81FC-B53B0F76A3A1

Q42703425-718A0764-ECCC-4E13-A0CD-A87F60E5A1DB

Q42703425-7B826DE0-D2C2-4028-9C9E-2021E8EA01BA

Q42703425-7EFCB359-828F-4CE5-AB03-5270FB460022

Q42703425-AFFF1E8C-B055-47A1-BB67-8F8D9FF08493

Q42703425-E0D3BE87-7C8A-4172-9D49-7226AEF102A0

Q42703425-F782429F-1D42-4B55-A263-F88E7F8F08EC

P304

Q42703425-A6000211-A44F-4765-9FF6-2DBE530A2D0E

P31

Q42703425-D74AB997-C9FD-4395-93E0-AA713F2000D3

P356

Q42703425-AB13A00D-17D1-4047-B8EA-80A092940EF9

P433

Q42703425-A1CCAA2D-9C3E-45E2-B586-16AFED86279B

P478

Q42703425-96BD0FD6-9E1F-4967-83FF-78FF0B3C8229

P50

Q42703425-7708F54F-ACC9-4FB8-9EBE-FC25EB1C2690

Q42703425-FC9323BB-FD1F-4FCA-8D2C-2F98D71D6741

P577

Q42703425-BB4A2720-C9BC-471E-B074-A0815187D95A

P698

Q42703425-E0174BC3-D6B8-486C-AA95-6CEEA8AFB6EC

P921

Q42703425-27EB51A6-9BDD-4D33-95C3-B1347A2DA42F

P356

J.TAAP.2014.10.006

P1433

Toxicology and Applied Pharmacology

P1476

Early biomarkers of doxorubicin-induced heart injury in a mouse model

@en

P2093

Carrie L Moland

http://www.w3.org/2001/XMLSchema#string

Eugene H Herman

http://www.w3.org/2001/XMLSchema#string

James C Fuscoe

http://www.w3.org/2001/XMLSchema#string

Joshua C Kwekel

http://www.w3.org/2001/XMLSchema#string

Kelly J Davis

http://www.w3.org/2001/XMLSchema#string

Levan Muskhelishvili

http://www.w3.org/2001/XMLSchema#string

Sherry M Lewis

http://www.w3.org/2001/XMLSchema#string

Susan Kerr

http://www.w3.org/2001/XMLSchema#string

Tao Han

http://www.w3.org/2001/XMLSchema#string

Varsha G Desai

http://www.w3.org/2001/XMLSchema#string

P304

221-229

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TAAP.2014.10.006

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

281

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25448438

http://www.w3.org/2001/XMLSchema#string

P921